Peroxisome Proliferator-Activated Receptor β/δ Activation Improves Angiotensin II-Induced Cardiac Hypertrophy in Vitro

Author： Sheng Li Ye Ping Liu Yong-xue Han Chun-guang Zhang Zhi-yi

ISSN： 1064-1963

Source： Clinical and Experimental Hypertension, Vol.30, Iss.2, 2008-02, pp. : 109-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Genetic Variants of Peroxisome Proliferator-Activated Receptor δ Are Associated with Gastric Cancer

By Jeon Christie Chang Shen-Chih Mu Lina Zhao Jinkou Rao Jian-Yu Lu Qing-Yi Zhang Zuo-Feng

Digestive Diseases and Sciences, Vol. 58, Iss. 10, 2013-10 ,pp. : 2881-2886

Springer Publishing Company

Access to resources Recommend Favorite

Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation

By Yoshida T. Yamagishi S. Nakamura K. Matsui T. Imaizumi T. Takeuchi M. Koga H. Ueno T. Sata M.

Diabetologia, Vol. 49, Iss. 12, 2006-12 ,pp. : 3094-3099

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor- in macrophage lipid homeostasis

By Lee C.-H. Evans R.M.

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 8, 2002-10 ,pp. : 331-335

Elsevier

Access to resources Recommend Favorite